Rockefeller University

Rockefeller Sr visited the university just once, at the urging of Rockefeller Jr, who was enthusiastic about the institute.[1]^: 475 Rockefeller Jr and his youngest son David visited more often.[14] David Rockefeller joined the board of trustees in 1940, was its chairman from 1950 to 1975, chaired the board's executive committee from 1975 to 1995, became honorary chairman and life trustee,[15] and remained active as a philanthropist until his death.[14]

Rockefeller Institute Hospital was renamed Rockefeller University Hospital.

The archives of Rockefeller University are at the Rockefeller Archive Center, established in 1974 as part of the university and organized as an independent foundation since 2008.[16]

• More than 71 heads of laboratories
• 200 research and clinical scientists
• 210 postdoctoral investigators
• 1,050 clinicians, technicians, administrative and support staff

To foster an interdisciplinary atmosphere among its laboratories, faculty members are grouped into one or more of ten interconnecting research areas:[17][18]

Rockefeller University admitted its first graduate students in 1955.[22] Today, about 255 graduate students are enrolled in the program, which offers doctoral degrees in the biomedical sciences, chemistry, and biophysics.[23] The university's organization on the basis of laboratories rather than a hierarchical departmental structure[24] extends to the graduate program, where laboratory research is the primary focus and students can meet degree requirements by participating in any combination of courses.[23] In partnership with neighboring Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, Rockefeller participates in the Tri-Institutional MD–PhD Program as well as a Tri-Institutional chemical biology Ph.D. program.[25]

Rockefeller ranks highly in the CWTS Leiden Ranking,[26] an international ranking of research impact.

Rockefeller faculty have made contributions to breakthroughs in biomedical sciences. Michael W. Young was one of several scientists who located genes that regulate the sleep–wake cycle in 1984.[27] In 1994, Jeffrey M. Friedman’s laboratory discovered leptin, a gene that influences appetite and weight.[28] Charles David Allis helped identify the first enzyme that modifies histones in 1996, providing early evidence that the DNA packaging material plays a crucial role in gene regulation.[29] In 1998, Roderick MacKinnon’s laboratory elucidated the structure and mechanism of a potassium channel, explaining how electrical signals are conveyed across cell membranes.[30] Titia de Lange was part of a team that found how telomeres protect chromosome ends, shedding light on the role of genome instability in cancer in 1999.[31] Robert B. Darnell led research that defined the molecular basis of fragile X syndrome, the second leading cause of intellectual disability, in 2001.[32] Vincent A. Fischetti was part of a group that developed a powerful agent that can target and wipe out anthrax bacteria in 2002.[33] Charles M. Rice helped produce an infectious form of the hepatitis C virus in laboratory cultures of human cells in 2005, leading directly to three new classes of hepatitis C drugs.[34] Elaine Fuchs helped define the stem cells that can initiate squamous cell carcinoma in 2011, and also characterized the signaling pathways that drive malignancy.[35] In 2013, Leslie B. Vosshall’s laboratory identified a gene in mosquitoes that is responsible for their attraction to humans and their sensitivity to the insect repellent DEET.[36] Ali Brivanlou's laboratory developed a method to grow embryos outside the uterus for up to 13 days in 2016, allowing scientists to study the earliest events of human development.[37]

In 2020, many Rockefeller scientists shifted the focus of their research in response to the COVID-19 pandemic.[38] Michel C. Nussenzweig pioneered a method to isolate and clone antibodies from people who successfully recovered from COVID-19 to design a treatment that prevents people from developing severe disease.[39] Jean-Laurent Casanova identified genetic mutations that are responsible for a subset of unexpectedly severe cases of COVID-19.[40]

Award affiliations taken from "The Rockefeller University » Nobel Laureates". Retrieved March 17, 2016.

Rockefeller University, as seen from the FDR Drive, New York, NY, 2011

There are more than 1,262 alumni.[55]

• David Albert, physicist and philosopher
• David Baltimore, recipient of Nobel Prize in Physiology & Medicine in 1975 for the discovery of reverse transcriptase. Has served as president of both the Rockefeller University and the California Institute of Technology.
• Michael Bratman, Durfee Professor of philosophy at Stanford University.
• Gerald Edelman, recipient of the 1972 Nobel Prize in Physiology or Medicine.
• Barbara Ehrenreich, social commentator and author of the 2001 book Nickel and Dimed: On (Not) Getting By In America.
• Alice F. Healy, psychologist, College Professor of Distinction at the University of Colorado Boulder
• Roy S. Herbst, oncologist, lung cancer researcher, and academic, Yale Cancer Center and Yale School of Medicine
• Bertil Hille, Professor of Physiology and Biophysics at the University of Washington, Lasker Award winner who specializes in cell signaling by ion channels, neurotransmitters and hormones.
• Mandë Holford, Professor in Chemistry at Hunter College with appointments at the American Museum of Natural History and Weill Cornell Medical College
• Jonathan Lear, the John U. Nef Distinguished Service Professor in the Committee on Social Thought and professor of philosophy at the University of Chicago, who specializes in Aristotle and psychoanalysis.
• Erich Jarvis, HHMI Investigator and head of the Neurogenetics of Language Laboratory at Rockefeller University.
• Seth Lloyd, physicist
• Harvey Lodish, professor of biology at the Massachusetts Institute of Technology and Founding Member of the Whitehead Institute for Biomedical Research
• Kiran Musunuru, professor of medicine at the Perelman School of Medicine at the University of Pennsylvania, co-founder of Verve Therapeutics, recipient of the Presidential Early Career Award for Scientists and Engineers
• Nina Papavasiliou, Helmholtz Professor in the Division of Immune Diversity at the German Cancer Research Center
• Manuel Elkin Patarroyo, Colombian pathologist who made the world's first attempt of synthetic vaccine for malaria. Recipient of Prince of Asturias Award in 1994.
• Vanessa Ruta, Head of the Laboratory of Neurophysiology and Behavior at Rockefeller University.
• Robert Sapolsky, Stanford professor, MacArthur "Genius" Grant recipient, and writer of numerous books on stress and natural history.
• Amos Smith, Rhodes-Thompson professor of chemistry at the University of Pennsylvania
• Leslie B. Vosshall, HHMI Investigator and the Robin Chemers Neustein Professor of Neurogenetics and Behavior at The Rockefeller University.
• Richard Wolfenden, professor of chemistry, biochemistry and biophysics at the University of North Carolina at Chapel Hill
• Gian-Paolo Dotto, professor and researcher, cancer domain.
• Martin Yarmush, Paul and Mary Monroe Chair and Distinguished Professor of Biomedical Engineering at Rutgers University and Founding Director of the Center for Engineering in Medicine at the Massachusetts General Hospital, Member of US National Academy of Engineering and National Academy of Inventors

Rockefeller University campus on the FDR Drive, New York, NY, 2021

Notable figures to emerge from the institution include Alexis Carrel, Peyton Rous, Hideyo Noguchi, Thomas Milton Rivers, Richard Shope, Thomas Francis Jr, Oswald T. Avery, Frederick Griffith, Colin MacLeod, Maclyn McCarty, Rebecca Lancefield, Wendell Meredith Stanley, René Dubos, Ashton Carter, and Cornelius P. Rhoads. Others attained eminence before being drawn to the university. Joshua Lederberg, who won the Nobel Prize in Physiology or Medicine in 1958, served as president of the university from 1978 to 1990.[56] Paul Nurse, who won the Nobel Prize in Physiology or Medicine in 2001, was president from 2003 to 2010.[57] (Before Nurse's tenure, Thomas Sakmar was acting-president from 2002.[58]) Barry Coller, who invented the Abciximab, currently serves as the Vice President for Medical Affairs.[59] In all, as of October 2020, 38 Nobel Prize recipients have been associated with the university. In the mid-1970s, the university attracted a few prominent academicians in the humanities, such as Saul Kripke.